Hanna, T. P. et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 371, m4087 (2020).
Cone, E. B. et al. Assessment of time-to-treatment initiation and survival in a cohort of patients with common cancers. JAMA Netw. Open 3, e2030072 (2020).
Article PubMed PubMed Central Google Scholar
Neal, R. D. et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br. J. Cancer 112, S92–S107 (2015).
Article PubMed PubMed Central Google Scholar
Robinson, H. S., Lee, S. S., Barocas, D. A. & Tosoian, J. J. Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer. Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-024-00840-0 (2024).
Laukhtina, E. et al. Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review. World J. Urol. 39, 4085–4099 (2021).
Article PubMed PubMed Central Google Scholar
Nguyen, D.-D. et al. Systematic review of time to definitive treatment for intermediate risk and high risk prostate cancer: are delays associated with worse outcomes? J. Urol. 205, 1263–1274 (2021).
Mohamad, O. et al. Delayed definitive management of localized prostate cancer: what do we know? Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-024-00876-2 (2024).
Article PubMed PubMed Central Google Scholar
Fanshawe, J. B. et al. Decision regret in patients with localised prostate cancer: a systematic review and meta-analysis. Eur. Urol. Oncol. 6, 456–466 (2023).
Jones, R. A. Decisional regret among men with prostate cancer: what is involved? JAMA Oncol. 8, 59–60 (2022).
Martínez-González, N. A. et al. Shared decision-making for prostate cancer screening and treatment: a systematic review of randomised controlled trials. Swiss Med. Wkly 148, w14584 (2018).
Comments (0)